Astrana Health (NASDAQ:ASTH) Given New $40.00 Price Target at BTIG Research

Astrana Health (NASDAQ:ASTH) had its price target lowered by BTIG Research from $45.00 to $40.00 in a research note released on Monday, Marketbeat.com reports. The firm currently has a buy rating on the stock.

A number of other research analysts have also weighed in on ASTH. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Jefferies Financial Group reiterated a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. TD Cowen decreased their price objective on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Finally, Barclays dropped their price objective on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a report on Monday, November 24th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $40.78.

Astrana Health Trading Down 1.8%

Shares of ASTH opened at $22.32 on Monday. Astrana Health has a fifty-two week low of $20.12 and a fifty-two week high of $39.97. The business has a 50-day moving average of $24.59 and a 200 day moving average of $26.87. The firm has a market cap of $1.26 billion, a P/E ratio of 117.48, a price-to-earnings-growth ratio of 0.68 and a beta of 0.91. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.40 and a current ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). The business had revenue of $956.05 million for the quarter, compared to the consensus estimate of $952.83 million. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.Astrana Health’s revenue for the quarter was up 99.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 EPS. As a group, research analysts forecast that Astrana Health will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC boosted its position in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after acquiring an additional 388 shares during the last quarter. GAMMA Investing LLC raised its stake in Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares in the last quarter. Strs Ohio bought a new stake in Astrana Health during the fourth quarter valued at approximately $40,000. Covestor Ltd grew its stake in Astrana Health by 210.6% in the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after buying an additional 2,192 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.